211 related articles for article (PubMed ID: 10197617)
1. Increased chromosome-type chromosome aberration frequencies as biomarkers of cancer risk in a blackfoot endemic area.
Liou SH; Lung JC; Chen YH; Yang T; Hsieh LL; Chen CJ; Wu TN
Cancer Res; 1999 Apr; 59(7):1481-4. PubMed ID: 10197617
[TBL] [Abstract][Full Text] [Related]
2. The association between frequencies of mitomycin C-induced sister chromatid exchange and cancer risk in arseniasis.
Liou SH; Chen YH; Loh CH; Yang T; Wu TN; Chen CJ; Hsieh LL
Toxicol Lett; 2002 Mar; 129(3):237-43. PubMed ID: 11888707
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: effects on levels of sister chromatid exchanges and chromosomal aberrations.
Tuimala J; Szekely G; Wikman H; Järventaus H; Hirvonen A; Gundy S; Norppa H
Mutat Res; 2004 Oct; 554(1-2):319-33. PubMed ID: 15450429
[TBL] [Abstract][Full Text] [Related]
4. Chromosomal aberrations in lymphocytes predict human cancer: a report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH).
Hagmar L; Bonassi S; Strömberg U; Brøgger A; Knudsen LE; Norppa H; Reuterwall C
Cancer Res; 1998 Sep; 58(18):4117-21. PubMed ID: 9751622
[TBL] [Abstract][Full Text] [Related]
5. Increased chromosome aberration frequencies in the Bowen's patients compared to non-cancerous skin lesions individuals exposed to arsenic.
Ghosh P; Banerjee M; De Chaudhuri S; Das JK; Sarma N; Basu A; Giri AK
Mutat Res; 2007 Aug; 632(1-2):104-10. PubMed ID: 17600756
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal aberrations and SCEs as biomarkers of cancer risk.
Norppa H; Bonassi S; Hansteen IL; Hagmar L; Strömberg U; Rössner P; Boffetta P; Lindholm C; Gundy S; Lazutka J; Cebulska-Wasilewska A; Fabiánová E; Srám RJ; Knudsen LE; Barale R; Fucic A
Mutat Res; 2006 Aug; 600(1-2):37-45. PubMed ID: 16814813
[TBL] [Abstract][Full Text] [Related]
7. Hypersensitivity to mitomycin C-induced sister chromatid exchange as a biomarker of past exposure to arsenic.
Liou SH; Gu TL; Chen CJ
Cancer Epidemiol Biomarkers Prev; 1996 Feb; 5(2):103-7. PubMed ID: 8850270
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health.
Bonassi S; Hagmar L; Strömberg U; Montagud AH; Tinnerberg H; Forni A; Heikkilä P; Wanders S; Wilhardt P; Hansteen IL; Knudsen LE; Norppa H
Cancer Res; 2000 Mar; 60(6):1619-25. PubMed ID: 10749131
[TBL] [Abstract][Full Text] [Related]
9. [Biomarkers of cytogenetic damage in humans and risk of cancer. The European Study Group on Cytogenetic Biomarkers and Health (ESCH)].
Lando C; Hagmar L; Bonassi S
Med Lav; 1998; 89(2):124-31. PubMed ID: 9673102
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic monitoring of pesticide sprayers.
Joksić G; Vidaković A; Spasojević-Tisma V
Environ Res; 1997 Nov; 75(2):113-8. PubMed ID: 9417841
[TBL] [Abstract][Full Text] [Related]
11. Age-related increase of baseline frequencies of sister chromatid exchanges, chromosome aberrations, and micronuclei in human lymphocytes.
Bolognesi C; Abbondandolo A; Barale R; Casalone R; Dalprà L; De Ferrari M; Degrassi F; Forni A; Lamberti L; Lando C; Migliore L; Padovani P; Pasquini R; Puntoni R; Sbrana I; Stella M; Bonassi S
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):249-56. PubMed ID: 9107430
[TBL] [Abstract][Full Text] [Related]
12. Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer.
Wei Q; Gu J; Cheng L; Bondy ML; Jiang H; Hong WK; Spitz MR
Cancer Res; 1996 Sep; 56(17):3975-9. PubMed ID: 8752166
[TBL] [Abstract][Full Text] [Related]
13. Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesions.
Wu X; Lippman SM; Lee JJ; Zhu Y; Wei QV; Thomas M; Hong WK; Spitz MR
Cancer Res; 2002 May; 62(10):2813-8. PubMed ID: 12019158
[TBL] [Abstract][Full Text] [Related]
14. Epidemiological evaluation of cytogenetic biomarkers as potential surrogate end-points for cancer.
Hagmar L; Strömberg U; Tinnerberg H; Mikoczy Z
IARC Sci Publ; 2004; (157):207-15. PubMed ID: 15055297
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of sister chromatid exchange and chromosome breaks in a cohort of untreated Hodgkin's disease patients.
Strom SS; Hess KR; Sigurdson AJ; Spitz MR; Liang JC
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):291-3. PubMed ID: 9107435
[TBL] [Abstract][Full Text] [Related]
16. Frequency of sister chromatid exchanges and micronuclei monitored over time in patients with early-stage breast cancer: results of an observational study.
Aristei C; Stracci F; Guerrieri P; Anselmo P; Armellini R; Rulli A; Barberini F; Latini P; Menghini AR
Cancer Genet Cytogenet; 2009 Jul; 192(1):24-9. PubMed ID: 19480933
[TBL] [Abstract][Full Text] [Related]
17. The genotoxic risk of underground coal miners from Turkey.
Donbak L; Rencuzogullari E; Yavuz A; Topaktas M
Mutat Res; 2005 Dec; 588(2):82-7. PubMed ID: 16337427
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of hepatitis B surface antigen carrier status among residents in the endemic area of chronic arsenicism in Taiwan.
Lu JN; Chen CJ
Anticancer Res; 1991; 11(1):229-33. PubMed ID: 2018356
[TBL] [Abstract][Full Text] [Related]
19. Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: a twelve-year follow-up study.
Huang YK; Huang YL; Hsueh YM; Yang MH; Wu MM; Chen SY; Hsu LI; Chen CJ
Cancer Causes Control; 2008 Oct; 19(8):829-39. PubMed ID: 18351295
[TBL] [Abstract][Full Text] [Related]
20. Chromosomal aberrations in arsenic-exposed human populations: a review with special reference to a comprehensive study in West Bengal, India.
Mahata J; Chaki M; Ghosh P; Das LK; Baidya K; Ray K; Natarajan AT; Giri AK
Cytogenet Genome Res; 2004; 104(1-4):359-64. PubMed ID: 15162065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
